Avalo Therapeutics to participate in upcoming investor conferences
AvaIо Therapeutics said management will participate in upcoming investor conferences, according to a company announcement.
WAYNE, Pa., Sept.
03, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc.
NASDAQ:AVTX, a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases, today announced that management will participate in the following i…